Spinomix Startup: Diagnostic Device Design for Next-Generation DNA Analysis
Milani partnered with Swiss MedTech startup Spinomix to develop the product design of a modular diagnostic platform for blood and DNA testing, from strategic positioning and product design to a market-ready solution. The result is a modular diagnostic system tailored to the needs of small and mid-sized laboratories, with a distinctive market position and a scalable product architecture.
Challenge: Closing a Gap in Compact Molecular Diagnostics
Traditional blood and DNA analysis systems were designed for high-throughput testing in large laboratories. As a result, they were often bulky, complex, and expensive, making them impractical for small and mid-sized labs. Swiss technology startup Spinomix recognized this market opportunity and developed an innovative automated sample preparation technology. The challenge was to transform this innovation into a compact, modular diagnostic platform optimized for smaller laboratories while meeting the highest standards of performance, usability, and medical requirements.
As a startup, Spinomix also faced tight budget and time constraints. The platform needed to be cost-efficient to manufacture in low production volumes while providing a flexible architecture that could be easily adapted to different system configurations. At the same time, the product required a distinctive visual identity that would differentiate Spinomix from established competitors and communicate innovation at first glance.
Approach: Turning Innovative Technology into a Market-Ready Medical Product
Working closely with Spinomix, Milani established the strategic foundation for both the brand and the product. We first defined the company's brand personality and translated it into a consistent design language across the product and brand identity. Milani also conducted interviews with laboratory professionals and prospective users from smaller laboratories to gain a deep understanding of user needs and clinical requirements.
From the outset, the product was engineered for efficient manufacturing. A simplified product architecture, reduced complexity, and a modular design enabled cost-efficient production while providing a scalable foundation for future product development.
Result: A Scalable Diagnostic Platform with a Distinct Market Position
The new Spinomix diagnostic platform was specifically designed for the needs of small and mid-sized laboratories. Its compact footprint requires significantly less bench space than conventional systems, making automated blood and DNA analysis accessible to laboratories that previously lacked suitable solutions.
The modular platform architecture allows the system to be easily adapted to different applications and future requirements. At the same time, the simplified product architecture reduced complexity, enabled cost-efficient manufacturing in low production volumes, and created a scalable foundation for future product development.
An integrated display, combined with the option to connect an external monitor, provides an intuitive user experience and supports laboratory professionals in efficiently operating and monitoring the analysis process. With its distinctive product identity, Spinomix gained a diagnostic platform that clearly differentiates the company from established competitors, communicates technological innovation at first glance, and provides a strong foundation for successful market entry.
Milani Services
- Strategy and definition of corporate identity
- Medical design / medical product design
- Brand Strategy & Brand Identity
- User Research & Stakeholder Interviews
- Product Development Support through Production Readiness
- Startup Support
